Incyte Corp | 99.1800 / +1.32% |
News
- BriaCell Announces Presentation at the 2021 Keystone Symposia Conference: Emerging Cell Therapies
01/12/2021 / 12:30 - GlobeNewswire - INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium
01/11/2021 / 23:03 - GlobeNewswire - US shares rise at open as Trump eyes smooth transition
01/08/2021 / 15:30 - TeleTrader - BriaCell Presents Clinical Data at the 2020 San Antonio Breast Cancer Symposium®
12/09/2020 / 15:00 - GlobeNewswire - Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
12/01/2020 / 08:00 - GlobeNewswire - MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte
11/30/2020 / 13:30 - GlobeNewswire - Inivata Appoints Dr. Alan Schafer as Chief Technology Officer
11/16/2020 / 13:00 - GlobeNewswire - XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement
11/11/2020 / 13:30 - GlobeNewswire - Merus Announces Poster Presentations on MCLA-145 at Society for Immunotherapy of Cancer
11/09/2020 / 14:00 - GlobeNewswire - Merus Announces Financial Results for the Third Quarter and Provides Business Update
11/05/2020 / 22:10 - GlobeNewswire - Calithera Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights
11/05/2020 / 22:06 - GlobeNewswire - MacroGenics Provides Update on Corporate Progress and Third Quarter 2020 Financial Results
11/04/2020 / 22:01 - GlobeNewswire - Zai Lab Announces First Patient Dosed in China in a Potentially Registrational Study of Retifanlimab in Patients with Endometrial Cancer
10/29/2020 / 12:30 - GlobeNewswire - BriaCell Breast Cancer Survival Data: 13.3 Months Versus 7.2-9.8 Months
10/21/2020 / 12:30 - GlobeNewswire - Zai Lab Announces First Patient Dosed in Greater China in the Global Phase 2/3 MAHOGANY Study of Margetuximab in Gastric and Gastroesophageal Junction Cancer
10/06/2020 / 13:30 - GlobeNewswire